Effect of Sulforaphane on the Vascular Status and Oxidative status of Type 2 Diabetes

Phase 1

• Conditions: Type 2 Diabetes; Metabolic and Endocrine - Diabetes

• Registration Number: ACTRN12612000692831
• Lead Sponsor: niversity of Queensland

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Study Start: 2012-06-28
• Last Update Posted: 13 January 2020

Recruitment & Eligibility

• Status: ot yet recruiting
• Sex: All
• Target Recruitment: 82

Inclusion Criteria

Medically-diagnosed with Type 2 diabetes without disease complications. Medication schedule must have been stable for at least 6 months and is not expected to change within the next 6 months. Must be able to attend the research clinic on 4 separate occasions over the 6 month-period of the trial. Must be prepared to take 6 plant-based capsules daily and refrain from eating cruciferous vegetables

Exclusion Criteria

Evident diabetic complications such as retinopathy, neuropathy and nephropathy. Those whose diabetic condition requires regular insulin. Smokers and those using recreational drugs. Males conusming more than 4 alcoholic drinks and females consuing more than 2 alcoholic drinks daily. Those with BMI > 30 or < 20.

Study & Design

• Study Type: Interventional
• Study Design: Not specified